GLYCOT THERAPEUTICS
GlycoT Therapeutics applies glycosylation technology for producing enzymes, oligosaccharides, glycopeptides and other glycoprotein products.
GLYCOT THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Address:
College Park, Maryland, United States
Country:
United States
Website Url:
http://www.glycot.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default WordPress Content Delivery Network Font Awesome Apache Wordpress Plugins Google Apps For Business ReCAPTCHA
Similar Organizations
Azaya Therapeutics
Azaya Therapeutics is a biotechnology company developing therapies for cancer and other serious medical conditions.
Penrose TherapeuTx
Penrose TherapeuTx specializes in technological advancements for treating advanced cancers using small-molecule therapies.
UVLrx Therapeutics
UVLrx Therapeutics is a biotechnology company that specializes in the fields of medical, healthcare, and therapeutics.
Current Employees Featured
Founder
Official Site Inspections
http://www.glycot.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "GlycoT Therapeutics"
About Us - GlycoT
Wang has the expertise, leadership, and motivation necessary to successfully guide GlycoT to fulfill its mission. He has published over 200 peer-reviewed scientific papers, most of them are …See details»
GlycoT Therapeutics - Crunchbase Company Profile & Funding
GlycoT Therapeutics is located in College Park, Maryland, United States. Who are GlycoT Therapeutics 's competitors? Alternatives and possible competitors to GlycoT Therapeutics …See details»
Contact us - GlycoT
Would you like to learn more about our technology, company, or services? Please email us anytime to learn more.See details»
GlycoT Therapeutics Company Profile 2024: Valuation, Funding ...
Lai-Xi Wang is the founder of GlycoT Therapeutics. Where is GlycoT Therapeutics headquartered? GlycoT Therapeutics is headquartered in College Park, MD. What industry is …See details»
GlycoT Therapeutics, Welcome to bwtech!
Jan 17, 2024 GlycoT Therapeutics’ solutions are based on technologies developed by the company’s Founder and President, Dr. Lai-Xi Wang, in his lab – first at University of Maryland, Baltimore, and later at University of Maryland, …See details»
GlycoT Therapeutics - VentureRadar
" GlycoT Therapeutics aims to apply its innovative and proprietary chemoenzymatic glycosylation technology for glycoengineering of therapeutic proteins such as monoclonal antibodies to …See details»
GlycoT Therapeutics - Contacts, Employees, Board Members
Organization. GlycoT Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. GlycoT …See details»
GlycoT Therapeutics LLC, a UM Ventures start-up company Signs ...
BALTIMORE, Sept. 14, 2020 /PRNewswire/ — GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, …See details»
GlycoT Therapeutics - Products, Competitors, Financials, …
GlycoT Therapeutics focuses on the development of chemoenzymatic glycosylation technology for the glycoengineering of therapeutic proteins, operating within the biotechnology and …See details»
GlycoT Therapeutics - Drug pipelines, Patents, Clinical trials
Nov 1, 2024 100 Translational Medicine associated with GlycoT Therapeutics. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. …See details»
GlycoT Therapeutics Grants Sublicense of Glycoengineering …
Sep 14, 2020 The agreement grants Daiichi Sankyo worldwide and non-exclusive rights to IP that GlycoT currently licenses from UMB and UMCP, and includes an undisclosed upfront …See details»
GlycoT Therapeutics Grants Sublicense of Glycoengineering …
BALTIMORE, Sept. 14, 2020 /PRNewswire/ -- GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, …See details»
GlycoT Therapeutics Grants Sublicense of ... - Markets Insider
Sep 14, 2020 GlycoT Therapeutics aims to apply its innovative and proprietary chemoenzymatic glycosylation technology for glycoengineering of therapeutic proteins such as monoclonal …See details»
GlycoT Therapeutics Grants Sublicense of Glycoengineering
BALTIMORE, Sept. 14, 2020 /PRNewswire/ -- GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, …See details»
Services - glycot.com
GlycoT provides flexible options for potential collaborators to test or evaluate our proprietary and innovative technology platform, We can provide you our key components of our technology …See details»
Pipelines - GlycoT
GlycoT is constructing a library of stable isotope labeled Fc glycopeptides as standards for mass-spec based absolute quantitation of Fc glycosylations of antibodies. Immunoglobulin G (IgG) is …See details»
GLYCO 26
May 15, 2023 We hope Glyco26 has created wonderful memories for you. GLYCO26 SYMPOSIUM SECRETARIAT [email protected]. © 2023 International Symposium on …See details»
Products - GlycoT
Endo-S and EndoS-D233Q mutant EndoS2-D184M mutant Endo-F3 and EndoF3-D165A mutant AlfC a-fucosidase and its glycoligase mutantSee details»
Projects - GlycoT
The technology has been exclusively licensed by GlycoT. Selected Reference. 1. Zhang X, Ou C, Liu H, Prabhu SK, Li C, Yang Q, Wang LX. General and Robust Chemoenzymatic Method for …See details»